MAP2K7 and melanoma: The NF1-mutant category refers to cases lacking either BRAF or RAS mutations, whereas NF1 mutations can also arise as a mechanism of resistance to RAF/MEK-targeted therapies in BRAF-mutated melanoma [3, 4].